However, despite its crucial role in cancer and other pathologies [64-66], only two physiological factors have been reported to negatively regulate RCHY1 at the protein level: RCHY1 itself [49] and calmodulin-dependent protein kinase II (CaMKII) [63]. Here, CAMK2G is linked to cancer.